Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
World Journal of Gastroenterology|April 10, 2013
Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis CJavier García-Samaniego, Miriam Romero, Rafael Granados, et al.
Plants (Basel, Switzerland)|October 27, 2022
The Interaction between Hydromulching and Arbuscular Mycorrhiza Improves Escarole Growth and Productivity by Regulating Nutrient Uptake and Hormonal BalanceMiriam Romero-Muñoz, Amparo Gálvez, Purificación A Martínez-Melgarejo, et al.
Antiviral Therapy|October 1, 2004
Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirinVincent Soriano, Marina Núñez, Nuria Camino, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 17, 2007
Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patientsBelén Ramos, Marina Núñez, Luz Martín-Carbonero, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2024
The overlap with metabolic dysfunction-associated steatotic liver disease negatively affects outcomes of primary biliary cholangitisMaría Hernández-Pérez, Daniel Riado, Eva Pena, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2005
Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patientsAna Lucía Rendón, Marina Núñez, Miriam Romero, et al.
Antiviral Therapy|August 3, 2007
Evolution of T-cell responses to hepatitis C virus (HCV) during pegylated interferon plus ribavirin treatment in HCV-monoinfected and in HCV/HIV-coinfected patientsLaura Capa, Vincent Soriano, Javier García-Samaniego, et al.
Revista Espanola De Enfermedades Digestivas|October 17, 2019
Quality of life study in asymptomatic patients with hepatitis CRaúl Honrubia López, Antonio Madejón Seiz, Miriam Romero Portales, et al.
World Journal of Gastroenterology|October 23, 2019
Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatmentAna Isabel Gil-García, Antonio Madejón, Irene Francisco-Recuero, et al.
AIDS (London, England)|April 18, 2003
Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patientsMayte Pérez-Olmeda, Marina Núñez, Miriam Romero, et al.
Pageof 7